Modulation of classifical pathway complement activation in rheumatic diseasesEL-GHOBAREY, A. F; HABIB, EL S. M; MOSELEY, H. L et al.Revue internationale de rhumatologie. 1984, Vol 14, Num 6, pp 379-387, issn 0294-474XArticle

Complexes between Clq and C3 or C4 : Novel and specific markers for classical complement pathway activationWOUTERS, Diana; WIESSENBERG, Hans D; HART, Margreet et al.Journal of immunological methods. 2005, Vol 298, Num 1-2, pp 35-45, issn 0022-1759, 11 p.Article

Revised nomenclature for human complement component C4*MAUFF, G; ABBAL, M; HAUPTMANN, G et al.European journal of immunogenetics. 1993, Vol 20, Num 4, pp 301-305, issn 0960-7420Article

Effect of RBCs on the activation of human complement by heparin-protamine complexesSHASTRI, K. A; PHILLIPS, M. J; RAZA, S et al.Blood. 1988, Vol 71, Num 1, pp 36-40, issn 0006-4971Article

Initiation of complement activationLACHMANN, P. J; HUGHES-JONES, N. C.Springer seminars in immunopathology. 1984, Vol 7, Num 2-3, pp 143-162, issn 0344-4325Article

Molecular organization and function of the complement systemMÜLLER-EBERHARD, H. J.Annual review of biochemistry. 1988, Vol 57, pp 321-347, issn 0066-4154Article

In vitro inhibition of the classical pathway of human complement by polymyxin BSYED SHAFI ASGHAR; BOOT, T; VAN DER HELM, H. J et al.Biochemical pharmacology. 1987, Vol 36, Num 18, pp 2927-2930, issn 0006-2952Article

Le système du complément, quelques données actuelles = Some recent data about complement systemDODU, J.Bulletin des Travaux de la Société de Pharmacie de Lyon. 1984, Vol 28, Num 2, pp 15-31, issn 0037-9107Article

The role of C1, C1-inactivator and C4 in modulating immune precipitationSCHIFFERLI, J. A; STEIGER, G; SCHAPIRA, M et al.Clinical and experimental immunology (Print). 1985, Vol 60, Num 3, pp 605-612, issn 0009-9104Article

Applications of complement determinations in human diseaseGLOVSKY, M. M.Annals of allergy. 1994, Vol 72, Num 6, pp 477-486, issn 0003-4738Article

High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement componentBOACKLE, R. J; CONNOR, M. H; VESELY, J et al.Molecular immunology. 1993, Vol 30, Num 3, pp 309-319, issn 0161-5890Article

Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1qSHAN-CHING YING; GEWURZ, A. T; HAIXIANG JIANG et al.The Journal of immunology (1950). 1993, Vol 150, Num 1, pp 169-176, issn 0022-1767Article

Kinetics of the classical complement activation cascadeHAVSTEEN, B. H; VARON, R.Journal of theoretical biology. 1990, Vol 145, Num 1, pp 47-64, issn 0022-5193, 18 p.Article

Clonage et séquençage de l'ADN complémentaire codant pour la protéine C1r du complément humainJournet, Agnès; Colomb, Maurice.1988, 212 p.Thesis

Liposome-induced activation of the classical complement pathway does not require immunoglobulinJIHAN MARJAN; ZONGCEN XIE; DEVINE, D. V et al.Biochimica et biophysica acta. Biomembranes. 1994, Vol 1192, Num 1, pp 35-44, issn 0005-2736Article

Activation of human complement by mouse and mouse/human chimeric monoclonal antibodiesSEINO, J; EVELEIGH, P; WARNAAR, S et al.Clinical and experimental immunology (Print). 1993, Vol 94, Num 2, pp 291-296, issn 0009-9104Article

Identification of residues 413-433 of plasma protein S as essential for binding to C4b-binding proteinFERNANDEZ, J. A; HEEB, M. J; GRIFFIN, J. H et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 22, pp 16788-16794, issn 0021-9258Article

Cold target competition analysis of the classical activation pathway of complement-mediated cytotoxicity : a non-interaction model for competing lysisTUSNADY, G; ERDEI, A; BAKACS, T et al.Molecular immunology. 1992, Vol 29, Num 11, pp 1347-1355, issn 0161-5890Article

Le complémentJOUVIN, M. H; KAZATCHKINE, M.Concours médical (Paris). 1987, Num 27, pp 2480-2488, issn 0010-5309Article

Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertaseSTRUNK, R. C; WEBSTER, R. O.Molecular immunology. 1985, Vol 22, Num 1, pp 37-43, issn 0161-5890Article

Soluble C3 proconvertase and convertase of the classical pathway of human complement: conditions of stabilization in vitroVILLIERS, M.-B; THIELENS, N. M; COLOMB, M. G et al.Biochemical journal (London. 1906). 1985, Vol 226, Num 2, pp 429-436, issn 0006-2936Article

Antibody-independent activation of C1, the first component of complement, by cardiolipinKOVACSOVICS, T; TSCHOPP, J; KRESS, A et al.The Journal of immunology (1950). 1985, Vol 135, Num 4, pp 2695-2700, issn 0022-1767Article

Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M bindingABDULLAH, Malikah; NEPLUEV, Igor; AFONINA, Galyna et al.Infection and immunity. 2005, Vol 73, Num 6, pp 3431-3439, issn 0019-9567, 9 p.Article

A novel ELISA for the evaluation of the classical pathway of complementZWIRNER, J; WITTIG, A; KREMMER, E et al.Journal of immunological methods. 1998, Vol 211, Num 1-2, pp 183-190, issn 0022-1759Article

Inhibition of the classical activation pathway of complement-mediated lysis by monoclonal antibodies to complement components C3c and C3dMUSHENS, R. E; BAKACS, T.Transfusion (Philadelphia, PA). 1992, Vol 32, Num 5, pp 430-434, issn 0041-1132Conference Paper